CN116999358A - 一种应用于皮肤屏障修护和舒缓的面膜及制备方法 - Google Patents
一种应用于皮肤屏障修护和舒缓的面膜及制备方法 Download PDFInfo
- Publication number
- CN116999358A CN116999358A CN202311003575.4A CN202311003575A CN116999358A CN 116999358 A CN116999358 A CN 116999358A CN 202311003575 A CN202311003575 A CN 202311003575A CN 116999358 A CN116999358 A CN 116999358A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw material
- phase
- mask
- stirring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000008591 skin barrier function Effects 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 230000008439 repair process Effects 0.000 title abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 67
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 41
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 23
- 229940101267 panthenol Drugs 0.000 claims abstract description 22
- 235000020957 pantothenol Nutrition 0.000 claims abstract description 22
- 239000011619 pantothenol Substances 0.000 claims abstract description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 20
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 20
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 239000004744 fabric Substances 0.000 claims abstract description 13
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims abstract description 9
- -1 polydimethylsiloxane Polymers 0.000 claims abstract description 8
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 7
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims abstract description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 7
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 7
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims description 50
- 239000000284 extract Substances 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 15
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 13
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 8
- 239000000811 xylitol Substances 0.000 claims description 8
- 235000010447 xylitol Nutrition 0.000 claims description 8
- 229960002675 xylitol Drugs 0.000 claims description 8
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 7
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 7
- 239000004475 Arginine Substances 0.000 claims description 7
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 7
- 108010087806 Carnosine Proteins 0.000 claims description 7
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims description 7
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 7
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 7
- 229940044199 carnosine Drugs 0.000 claims description 7
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims description 7
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 7
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 claims description 7
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 229920006037 cross link polymer Polymers 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- YPUZOECTETYPRF-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrimidine-2-carboxylic acid Chemical compound OC(=O)C1NCC=CN1 YPUZOECTETYPRF-UHFFFAOYSA-N 0.000 claims description 5
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 5
- 240000001341 Reynoutria japonica Species 0.000 claims description 5
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 5
- 244000269722 Thea sinensis Species 0.000 claims description 5
- 239000004359 castor oil Substances 0.000 claims description 5
- 235000019438 castor oil Nutrition 0.000 claims description 5
- 229940059958 centella asiatica extract Drugs 0.000 claims description 5
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 5
- 229930182478 glucoside Natural products 0.000 claims description 5
- 150000008131 glucosides Chemical class 0.000 claims description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 5
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 5
- 239000001331 rosmarinus officinalis leaf Substances 0.000 claims description 5
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 claims description 5
- 229960003232 troxerutin Drugs 0.000 claims description 5
- 241001530056 Athelia rolfsii Species 0.000 claims description 4
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 4
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 4
- 229940119217 chamomile extract Drugs 0.000 claims description 4
- 235000020221 chamomile extract Nutrition 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 229940072008 glycyrrhiza glabra extract Drugs 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 230000001815 facial effect Effects 0.000 abstract description 38
- 230000002195 synergetic effect Effects 0.000 abstract description 6
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 45
- 238000012360 testing method Methods 0.000 description 19
- 239000010410 layer Substances 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 9
- PUGFCQQOYJMKOO-UHFFFAOYSA-N n-(3-hexadecoxy-2-hydroxypropyl)-n-(2-hydroxyethyl)hexadecanamide Chemical compound CCCCCCCCCCCCCCCCOCC(O)CN(CCO)C(=O)CCCCCCCCCCCCCCC PUGFCQQOYJMKOO-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 210000002615 epidermis Anatomy 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 210000001339 epidermal cell Anatomy 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 229960005150 glycerol Drugs 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000036571 hydration Effects 0.000 description 4
- 238000006703 hydration reaction Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 210000002747 omentum Anatomy 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- XJFGDLJQUJQUEI-UHFFFAOYSA-N dodecyl decanoate dodecyl octanoate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC.CCCCCCCCCCCCOC(=O)CCCCCCCCC XJFGDLJQUJQUEI-UHFFFAOYSA-N 0.000 description 2
- 210000000887 face Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- GCKMFJBGXUYNAG-HLXURNFRSA-N Methyltestosterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 GCKMFJBGXUYNAG-HLXURNFRSA-N 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 206010040830 Skin discomfort Diseases 0.000 description 1
- 240000009022 Smilax rotundifolia Species 0.000 description 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000000438 stratum basale Anatomy 0.000 description 1
- 210000000498 stratum granulosum Anatomy 0.000 description 1
- 210000000437 stratum spinosum Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229940085503 testred Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
本发明涉及化妆品领域，特别是，涉及一种应用于皮肤屏障修护和舒缓的面膜及制备方法。所述面膜包括面膜面料及附着在面料上的面膜液，按重量份计，所述面膜液包括：A相原料、B相原料和D相原料，A相原料组分包括：水43.5～88份、甘油1～3份和透明质酸钠0.01～0.5份；B相原料组分包括：鲸蜡基‑PG羟乙基棕榈酰胺0.01～0.5份、椰油醇‑辛酸酯/癸酸酯1～3份、聚二甲基硅氧烷0.01～1份、氢化聚异丁烯0.01～0.3份和白池花籽油0.01～0.5份；D相原料组分包括：水2～10份和泛醇1～3份。本发明将透明质酸钠、泛醇和鲸蜡基‑PG羟乙基棕榈酰胺合理配伍，使三者在修复受损皮肤以及增强皮肤屏障方面表现出协同增效的作用。
Description
技术领域
本发明涉及化妆品领域，特别是，涉及一种应用于皮肤屏障修护和舒缓的面膜及制备方法。
背景技术
面膜是一种可以用于面部肌肤保养和修复的特殊护肤产品。它通常是以薄布或泥状的形式涂在面部，然后静置一段时间，让其中的活性物质渗透到皮肤里，以达到补水、美白、抗皱和舒缓等美容效果。
皮肤屏障是皮肤表面的一层保护层，主要是由角质层构成，起着防止水分流失和外界有害物质侵入的作用。但随着环境的恶化、不规律的作息以及不正确的护理方法，大多数都市人群面临皮肤屏障受损问题，皮肤变得脆弱、敏感，严重者甚至影响到生活和工作。
用于修复皮肤屏障且附带其他美容效果的面膜受到了越来越多人的追捧，但市场上的面膜参差不齐，且多数面膜只能达到基础的保湿效果。并且频繁使用面膜会使表皮细胞吸水膨胀，角质层堵塞，皮脂排泄不畅，积聚在毛囊中，导致形成水合性皮炎，进一步破坏皮肤屏障功能。有鉴于此，亟待一种能够改善皮肤屏障且不会引起水合性皮炎的面膜，从而来解决皮肤屏障受损问题。
发明内容
本发明的目的在于提供一套以含有透明质酸钠、泛醇和鲸蜡基-PG羟乙基棕榈酰胺为原料的面膜。其中，透明质酸钠是一种天然产生于人体组织的多糖类物质，它能深入真皮层，提高真皮层的锁水能力。同时，透明质酸钠具有润滑作用，可以使皮肤更加光滑，减少皱纹的出现。泛醇，也被称为维生素原B5，它可以渗入皮肤表层，增强皮肤锁水能力，持久保持水分。同时，它具有一定的抗炎作用，缓解肌肤不适感，并促进肌肤细胞的再生和修复，还能够给组织细胞提供代谢能量，促进细胞分化，强化皮肤屏障功能。鲸蜡基-PG羟乙基棕榈酰胺是一种神经酰胺类似物，能增强表皮细胞的内聚力，改善皮肤屏障作用，并通过氢键形成分子缔合体，促进表皮的水合作用，提高皮肤的保水能力。
本发明的面膜通过透明质酸钠、泛醇和鲸蜡基-PG羟乙基棕榈酰胺三者协同作用，可以提高皮肤锁水能力，同时促进皮肤屏障的修复，改善并提高皮肤屏障功能。
本发明的目的通过以下技术方案实现：
本发明提供一种应用于皮肤屏障修护和舒缓的面膜，包括面膜面料及附着在面料上的面膜液，按重量份计，所述面膜液包括：A相原料、B相原料和D相原料，A相原料组分包括：水43.5～88份、甘油1～3份和透明质酸钠0.01～0.5份；
B相原料组分包括：鲸蜡基-PG羟乙基棕榈酰胺0.01～0.5份、椰油醇-辛酸酯/癸酸酯1～3份、聚二甲基硅氧烷0.01～1份、氢化聚异丁烯0.01～0.3份和白池花籽油0.01～0.5份；
D相原料组分包括：水2～10份和泛醇1～3份。
优选地，所述A相原料组分还包括丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物0.01～0.5份和水解小核菌胶0.01～0.5份。
优选地，所述D相原料组分还包括积雪草提取物0.001～0.2份、虎杖根提取物0.001～0.2份、黄芩根提取物0.001～0.2份、茶叶提取物0.001～0.2份、光果甘草提取物0.001～0.05份、母菊花提取物0.001～0.05份、迷迭香叶提取物0.001～0.05份、1,2-戊二醇0.01～1份、木糖醇基葡糖苷0.01～0.2份、脱水木糖醇0.01～0.1份、木糖醇0.01～0.05份、甘草酸二钾0.01～0.5份、四氢甲基嘧啶羧酸0.01～0.5份、曲克芦丁0.01～0.2份和PEG-40氢化蓖麻油0.01～0.2份。
优选地，按重量份计，所述面膜液组分还包括C相原料组份，
C相原料组份：水5～15份、1,2-己二醇0.01～1份、肌肽0.01～0.1份、精氨酸0.01～0.5份、丁二醇0.1～3份、辛酰羟肟酸0.01～0.1份、乙基己基甘油0.01～0.1份。
本发明提供一种所述面膜的制备方法，包括以下步骤：
S1、将A相原料搅拌并升温至70～90℃，恒温20～30min；
S2、将B相原料搅拌并升温至70～90℃，恒温20～30min，加入A相中，搅拌；
S3、降温至40～45℃时，将D相原料加入，搅拌；
S4、过滤后得到产品面膜。
优选地，面膜液组分还包括C相原料组份，
C相原料组份：水5～15份、1,2-己二醇0.01～1份、肌肽0.01～0.1份、精氨酸0.01～0.5份、丁二醇0.1～3份、辛酰羟肟酸0.01～0.1份、乙基己基甘油0.01～0.1份；
该制备方法在步骤S2和S3之间还包括：S2’、降温至50～70℃时，将C相原料加入，搅拌。
优选地，步骤S2’中，混匀搅拌速度为500～2000rpm；步骤S2’的降温过程，其速率为0.2～1℃/min，采用正反交替搅拌法，搅拌时间为10～60min。
优选地，步骤S1中，A相混匀搅拌速度为500～1000rpm；步骤S2中，混匀搅拌速度为1500～3500rpm；步骤S3中，混匀搅拌速度为30～2000rpm；步骤S2至步骤S3的降温过程，其速率为0.2～1℃/min。
优选地，采用正反交替搅拌法，搅拌时间为10～60min。
具体地，本发明提供一种应用于皮肤屏障修护和舒缓的面膜面膜，包括面膜面料及附着在面料上的面膜液，所述面膜液包括A相原料、B相原料、C相原料和D相原料，由以下重量份的原料制成：
A相原料组份：水43.5～88份、甘油1～3份、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物0.01～0.5份、透明质酸钠0.01～0.5份、水解小核菌胶0.01～0.5份。
B相原料组份：椰油醇-辛酸酯/癸酸酯1～3份、聚二甲基硅氧烷0.01～1份、鲸蜡基-PG羟乙基棕榈酰胺0.01～0.5份、氢化聚异丁烯0.01～0.3份、白池花籽油0.01～0.5份。
C相原料组份：水5～15份、1,2-己二醇0.01～0.5份、肌肽0.01～0.1份、精氨酸0.01～0.5份、丁二醇0.1～3份、辛酰羟肟酸0.01～0.1份、乙基己基甘油0.01～0.1份。
D相原料组份：水2～10份、积雪草提取物0.001～0.2份、虎杖根提取物0.001～0.2份、黄芩根提取物0.001～0.2份、茶叶提取物0.001～0.2份、光果甘草提取物0.001～0.05份、母菊花提取物0.001～0.05份、迷迭香叶提取物0.001～0.05份、泛醇1～3份、1,2-戊二醇0.01～1份、木糖醇基葡糖苷0.01～0.2份、脱水木糖醇0.01～0.1份、木糖醇0.01～0.05份、甘草酸二钾0.01～0.5份、四氢甲基嘧啶羧酸0.01～0.5份、曲克芦丁0.01～0.2份、PEG-40氢化蓖麻油0.01～0.2份。
进一步地，所述的一种面膜，包括面膜面料及附着在面料上的面膜液，所述面膜液由以下重量份的原料组成：
A相原料组份：水72.232份、甘油2.1份、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物0.4份、透明质酸钠0.23份、水解小核菌胶0.0825份。
B相原料组份：椰油醇-辛酸酯/癸酸酯1.7份、聚二甲基硅氧烷0.6份、鲸蜡基-PG羟乙基棕榈酰胺0.35份、氢化聚异丁烯0.25份、白池花籽油0.23份。
C相原料组份：水10份、1,2-己二醇0.6份、肌肽0.0825份、精氨酸0.1份、丁二醇2份、辛酰羟肟酸0.095份、乙基己基甘油0.0825份。
D相原料组份：水6份、积雪草提取物0.08份、虎杖根提取物0.035份、黄芩根提取物0.035份、茶叶提取物0.02份、光果甘草提取物0.035份、母菊花提取物0.025份、迷迭香叶提取物0.025份、泛醇1份、1,2-戊二醇0.75份、木糖醇基葡糖苷0.09份、脱水木糖醇0.098份、木糖醇0.045份、甘草酸二钾0.23份、四氢甲基嘧啶羧酸0.23份、曲克芦丁0.085份、PEG-40氢化蓖麻油0.0825份。
所述的面膜的制备方法，包括以下步骤：
S1、将A相原料搅拌并升温至70～90℃，恒温20～30min；
S2、将B相原料搅拌并升温至70～90℃，恒温20～30min，加入A相中，搅拌；
S3、降温至50～70℃时，将C相原料加入，搅拌；
S4、降温至40～45℃时，将D相原料加入，搅拌；
S5、过滤后即为产品。
进一步地，步骤S1中，A相混匀搅拌速度为500～1000rpm；步骤S2中，混匀搅拌速度为1500～3500rpm；进一步地，步骤S3中，混匀搅拌速度为500～2000rpm；进一步地，步骤S4中，混匀搅拌速度为30～2000rpm；进一步地，步骤S2至步骤S3和S4的降温过程，其速率为0.2～1℃/min。
进一步地，搅拌过程采用正反交替搅拌法，搅拌时间为10～60min。
本发明面膜中含有透明质酸钠、泛醇和鲸蜡基-PG羟乙基棕榈酰胺等功能性成分。本发明修复改善皮肤屏障途径有以下几点：一是椰油醇-辛酸酯/癸酸酯和聚二甲基硅氧烷在皮肤表面形成一层油膜，可以起到封闭锁水，长效保湿，防风防尘的效果；二是透明质酸钠渗透到皮肤深处，提高组织细胞含水量，泛醇可以增强角质层脂质和角蛋白的流动性来补偿水合作用的减少，同时泛醇补充外源代谢能量来改善表皮细胞的状态从而形成“细胞膜”—一层层排列整齐的角质细胞；；三是补充外源细胞间的脂质，在表皮细胞间形成一张脂质网膜来改善角质细胞间的内聚力，并通过氢键形成分子缔合体，促进表皮的水合作用，提高皮肤的保水能力，并协同泛醇补充组织细胞能量一同改善皮肤屏障。
本发明通过油膜、“细胞膜”和脂质网膜形成的三重膜来改善皮肤屏障功能。皮肤的表皮是重要皮肤屏障组成之一，包含角质层、透明层、颗粒层、有棘层和基底层。第一层油膜作用的位置为角质层，第二层膜细胞膜作用的位置为表皮中的活细胞，第三层膜脂质网膜作用的位置为表皮中的活细胞细胞间质。从而使表皮层得到整体性的改善。
本发明的优点在于：将透明质酸钠、泛醇和鲸蜡基-PG羟乙基棕榈酰胺三者结合作用以达到协同增效的效果，作用于皮肤后显著提升了保湿能力，同时能增强肌肤活性和改善肌肤干燥问题，对皮肤屏障受损问题有很好的修复和改善效果，并且此配方温和无刺激。
本发明具有以下优点：
第一、本发明面膜具有椰油醇-辛酸酯/癸酸酯、聚二甲基硅氧烷、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物和水解小核菌胶等，在皮肤表面形成一层薄膜，防止皮肤水分过度流失。
第二、本发明面膜具有透明质酸钠、甘油和泛醇，可渗透至皮下，提高皮肤组织的含水量。并且泛醇能够增强皮肤屏障功能，并且促进皮肤角化功能，能够有效的预防和改善皮肤粗糙现象。
第三、本发明面膜中的鲸蜡基-PG羟乙基棕榈酰胺填充了角质层之间的脂质，增强表皮细胞的内聚力，改善皮肤屏障作用，并通过氢键形成分子缔合体，促进表皮的水合作用，提高皮肤的保水能力。同时通过与氢化聚异丁烯、白池花籽油等成分的搭配，协同作用修复皮肤屏障功能。
第四、本发明将透明质酸钠、泛醇和鲸蜡基-PG羟乙基棕榈酰胺合理配伍，使三者在修复受损皮肤以及增强皮肤屏障方面表现出协同增效的作用。
第五，本发明所用的多种植物提取物起到减缓皮肤炎性因子、改善敏感性皮肤和增强皮肤屏障的作用。
附图说明
图1为实施例9的经皮水分流失TEWL值测试结果示意图；
图2为实施例9的经皮水分流失TEWL值相对初始值均值的变化率示意图(“*”表示该时间点测试值与初始值之间差异有统计学意义)；
图3为实施例10的红区分析a*值测试结果示意图；
图4为实施例10的红区分析a*值相对初始值均值的变化率示意图(“*”表示该时间点测试值与初始值之间差异有统计学意义)；
图5为实施例10的样品使用前后面部红区变化示意图。
具体实施方式
需要说明的是，在不冲突的情况下，本发明中的实施例及实施例中的特征是可以相互结合。下面将结合实施例进一步说明本发明的效果。
实施例1
本发明一种应用于皮肤屏障修护和舒缓的面膜，包括面膜面料及附着在面料上的面膜液，所述面膜液由以下重量份的原料组成：
A相组份：水72.232份、甘油2.1份、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物0.4份、透明质酸钠0.23份、水解小核菌胶0.0825份。
B相组份：椰油醇-辛酸酯/癸酸酯1.7份、聚二甲基硅氧烷0.6份、鲸蜡基-PG羟乙基棕榈酰胺0.35份、氢化聚异丁烯0.25份、白池花籽油0.23份。
C相组份：水10份、1,2-己二醇0.6份、肌肽0.0825份、精氨酸0.1份、丁二醇2份、辛酰羟肟酸0.095份、乙基己基甘油0.0825份。
D相组份：水6份、积雪草提取物0.08份、虎杖根提取物0.035份、黄芩根提取物0.035份、茶叶提取物0.02份、光果甘草提取物0.035份、母菊花提取物0.025份、迷迭香叶提取物0.025份、泛醇1份、1,2-戊二醇0.75份、木糖醇基葡糖苷0.09份、脱水木糖醇0.098份、木糖醇0.045份、甘草酸二钾0.23份、四氢甲基嘧啶羧酸0.23份、曲克芦丁0.085份、PEG-40氢化蓖麻油0.0825份。
所述的面膜的制备方法，包括以下步骤：
S1、将A相原料搅拌并升温至80℃，恒温25min；
S2、将B相原料搅拌并升温至85℃，恒温30min，加入A相中，搅拌；
S3、降温至65℃时，将C相原料加入，搅拌；
S4、降温至45℃时，将D相原料加入，搅拌；
S5、过滤后即为产品。
进一步地，步骤S1中，A相混匀搅拌速度为800rpm；步骤S2中，混匀搅拌速度为2000rpm；进一步地，步骤S3中，混匀搅拌速度为1000pm；
进一步地，步骤S4中，混匀搅拌速度为1000rpm；进一步地，步骤S2至步骤S3和S4的降温过程，其速率为0.6℃/min。
进一步地，搅拌过程采用正反交替搅拌法，搅拌时间为45min。
实施例2
与实施例1的区别在于：以等量的水代替鲸蜡基-PG羟乙基棕榈酰胺。
实施例3
与实施例1的区别在于：以等量的水代替泛醇。
实施例4
与实施例1的区别在于：以等量的水代替透明质酸钠。
实施例5
与实施例1的区别在于：以等量的水代替泛醇、鲸蜡基-PG羟乙基棕榈酰胺。
实施例6
与实施例1的区别在于：以等量的水代替透明质酸钠、鲸蜡基-PG羟乙基棕榈酰胺。
实施例7
与实施例1的区别在于：以等量的水代替透明质酸钠和泛醇。
将实施例1-7制备的面膜进行经皮水分流失测定。具体方法为：每组面膜随机选用10名皮肤屏障受损的志愿者(年龄25-54岁)进行试用。每天洁面后取出面膜，敷于面部，避开眼周、唇部使用，剩余精华可涂抹于颈部肌肤，15-20分钟后，取下面膜，轻柔按摩至精华吸收，每两天使用一次，期间不使用其他护肤品。面膜使用前和使用四周后分别用经皮水分流失测定仪(Aqua Flux)探头置于颊部皮肤同一位置，保持水平测定经皮水分流失TEWL值。同一个受试者的测试由同一仪器、同一测试人员进行。平行试验测定3次，取平均值，记录经皮水分流失TEWL值。测试结果见表1。
表1实施例1-7经皮水分流失测试结果
由上表可知，相比于实施例2-7，实施例1中的透明质酸钠、泛醇和鲸蜡基-PG羟乙基棕榈酰胺三者协同增效，经皮水分流失TEWL值显著降低，说明皮肤的锁水能力增强，皮肤屏障功能得到改善。
实施例8
对配制产品进行性能指标测试，结果如下：
面膜
颜色：白色液体；
形状：有粘度液体；
气味：有气味(轻微原料特征气味)；
耐热稳定性测试(42℃*24h)：合格；
耐寒稳定性测试(-15℃*24h)：合格；
离心2000rpm,30min：合格。
实施例9
经皮水分流失TEWL测定
将实施例1制备的面膜进行经皮水分流失测定，测试仪器为皮肤水分流失测试仪(Aqua Flux)。具体测试方法为：选用30名皮肤屏障受损的志愿者(年龄25-54岁)进行试用。洁面后取出面膜，敷于面部，请避开眼周、唇部使用，剩余精华可涂抹于颈部肌肤，15-20分钟后，取下面膜，轻柔按摩至精华吸收，每两天使用一次，期间不使用其他护肤品。面膜使用前、使用两周后和使用四周后分别用经皮水分流失测定仪(Aqua Flux)探头置于颊部皮肤同一位置，保持水平测定经皮水分流失TEWL值。同一个受试者的测试由同一仪器、同一测试人员进行。每次测定前，清洁探头，同时受试人员应用清水洗脸，保持放松，静坐30min，接受测试。测试结果见表2、表3、图1和图2。经皮水分流失TEWL值越小，说明经皮水分流失越慢。
表2经皮水分流失TEWL值描述性统计结果(n＝30)
表3经皮水分流失TEWL值描述性统计结果(n＝30)
统计分析结果：“*”：差异有统计学意义(P<0.05)；“-”：差异无统计学意义(P≥0.05)。
实施例10
面部成像测试-红区分析a*值
将实施例1制备的面膜进行面部成像测试，测试仪器为面部图像分析仪(VISIA-CR)。具体测试方法为：选用30名皮肤屏障受损的志愿者(年龄25-54岁)进行试用。洁面后取出面膜，敷于面部，请避开眼周、唇部使用，剩余精华可涂抹于颈部肌肤，15-20分钟后，取下面膜，轻柔按摩至精华吸收，每两天使用一次，期间不使用其他护肤品。面膜使用前、使用两周后和使用四周后分别用面部图像分析仪(VISIA-CR)对面部皮肤进行多角度成像。本次测试提供受试者面部正面标准光1、标准光2、橙光和交叉偏振光4种光源下采集的图片。对交叉偏振光下导出的红区图片进行图像分析，得到量化指标红区分析a*值，用于评估面部皮肤发红、敏感状态的改善情况。同一个受试者的测试由同一仪器、同一测试人员进行。每次测定前受试人员应用清水洗脸，保持放松，静坐30min，接受测试。测试结果见表4、表5、图3、图4和图5。红区分析a*值越大，说明皮肤发红情况越严重。
表4红区分析a*值描述性统计结果(n＝30)
表5经红区分析a*值统计分析结果(n＝30)
统计分析结果：“*”：差异有统计学意义(P<0.05)；“-”：差异无统计学意义(P≥0.05)。
综上所述，使用本发明实施例1的面膜4周后，经皮水分流失(TEWL)从23.58g/m2h降低到17.25g/m2h，说明皮肤锁水能力增强，保湿度增加，皮肤屏障层得到强化；红区分析a*值从30.8513降低到21.5465，有效改善面部皮肤发红，增强皮肤屏障功能。
最后所应说明的是，以上实施例仅用以说明本发明的技术方案而非限制。尽管参照实施例对本发明进行了详细说明，本领域的普通技术人员应当理解，对本发明的技术方案进行修改或者等同替换，都不脱离本发明技术方案的精神和范围，其均应涵盖在本发明的权利要求范围当中。
Claims (9)
1.一种应用于皮肤屏障修护和舒缓的面膜，包括面膜面料及附着在面料上的面膜液，其特征在于，按重量份计，所述面膜液包括：A相原料、B相原料和D相原料，
A相原料组分包括：水43.5～88份、甘油1～3份和透明质酸钠0.01～0.5份；
B相原料组分包括：鲸蜡基-PG羟乙基棕榈酰胺0.01～0.5份、椰油醇-辛酸酯/癸酸酯1～3份、聚二甲基硅氧烷0.01～1份、氢化聚异丁烯0.01～0.3份和白池花籽油0.01～0.5份；
D相原料组分包括：水2～10份和泛醇1～3份。
2.根据权利要求1所述的面膜，其特征在于，所述A相原料组分还包括丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物0.01～0.5份和水解小核菌胶0.01～0.5份。
3.根据权利要求1所述的面膜，其特征在于，所述D相原料组分还包括积雪草提取物0.001～0.2份、虎杖根提取物0.001～0.2份、黄芩根提取物0.001～0.2份、茶叶提取物0.001～0.2份、光果甘草提取物0.001～0.05份、母菊花提取物0.001～0.05份、迷迭香叶提取物0.001～0.05份、1,2-戊二醇0.01～1份、木糖醇基葡糖苷0.01～0.2份、脱水木糖醇0.01～0.1份、木糖醇0.01～0.05份、甘草酸二钾0.01～0.5份、四氢甲基嘧啶羧酸0.01～0.5份、曲克芦丁0.01～0.2份和PEG-40氢化蓖麻油0.01～0.2份。
4.根据权利要求1-3任一所述的面膜，其特征在于，按重量份计，所述面膜液组分还包括C相原料组份，
C相原料组份：水5～15份、1,2-己二醇0.01～1份、肌肽0.01～0.1份、精氨酸0.01～0.5份、丁二醇0.1～3份、辛酰羟肟酸0.01～0.1份、乙基己基甘油0.01～0.1份。
5.一种权利要求1-3任一所述面膜的制备方法，包括以下步骤：
S1、将A相原料搅拌并升温至70～90℃，恒温20～30min；
S2、将B相原料搅拌并升温至70～90℃，恒温20～30min，加入A相中，搅拌；
S3、降温至40～45℃时，将D相原料加入，搅拌；
S4、过滤后得到产品面膜。
6.根据权利要求5所述的面膜的制备方法，其特征在于，面膜液组分还包括C相原料组份，
C相原料组份：水5～15份、1,2-己二醇0.01～1份、肌肽0.01～0.1份、精氨酸0.01～0.5份、丁二醇0.1～3份、辛酰羟肟酸0.01～0.1份、乙基己基甘油0.01～0.1份；
该制备方法在步骤S2和S3之间还包括：S2’、降温至50～70℃时，将C相原料加入，搅拌。
7.根据权利要求6所述的面膜的制备方法，其特征在于，步骤S2’中，混匀搅拌速度为500～2000rpm；步骤S2’的降温过程，其速率为0.2～1℃/min，采用正反交替搅拌法，搅拌时间为10～60min。
8.根据权利要求5所述的面膜的制备方法，其特征在于：步骤S1中，A相混匀搅拌速度为500～1000rpm；步骤S2中，混匀搅拌速度为1500～3500rpm；步骤S3中，混匀搅拌速度为30～2000rpm；步骤S2至步骤S3的降温过程，其速率为0.2～1℃/min。
9.根据权利要求5所述的面膜的制备方法，其特征在于：采用正反交替搅拌法，搅拌时间为10～60min。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311003575.4A CN116999358A (zh) | 2023-08-10 | 2023-08-10 | 一种应用于皮肤屏障修护和舒缓的面膜及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311003575.4A CN116999358A (zh) | 2023-08-10 | 2023-08-10 | 一种应用于皮肤屏障修护和舒缓的面膜及制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116999358A true CN116999358A (zh) | 2023-11-07 |
Family
ID=88563315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311003575.4A Pending CN116999358A (zh) | 2023-08-10 | 2023-08-10 | 一种应用于皮肤屏障修护和舒缓的面膜及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116999358A (zh) |
-
2023
- 2023-08-10 CN CN202311003575.4A patent/CN116999358A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7195324B2 (ja) | 肌修復用スキンケア組成物及びその調製方法 | |
| KR102165567B1 (ko) | 피부 보습 효과가 우수한 화장료 조성물 | |
| CN111686029A (zh) | 一种抗衰祛皱组合物 | |
| CN109394645B (zh) | 一种涂抹式水光针精华及其制备方法 | |
| CN111529417A (zh) | 一种具有抗蓝光功效修护眼霜及其制备方法 | |
| CN111973508A (zh) | 一种舒缓保湿的抗初老组合物 | |
| CN110638707A (zh) | 一种眼部护理霜及其制备方法 | |
| CN114306165B (zh) | 一种保湿组合物及其制备方法 | |
| CN110974758A (zh) | 一种保湿面膜及其制备方法 | |
| CN111840124A (zh) | 寡肽水感靓肤面膜及其精华液及精华液的制备方法 | |
| CN110960458A (zh) | 一种保湿精华乳液及其制备方法 | |
| CN115517999B (zh) | 一种抗衰老组合物及其在美容护肤中的应用 | |
| CN110721148A (zh) | 一种多方位提拉紧致多肽精华液及其制备方法 | |
| CN114246817A (zh) | 一种祛皱组合物及其制备方法和应用 | |
| US20220378690A1 (en) | Compositions and methods for treating skin | |
| KR101254330B1 (ko) | 눈가 주름 개선용 화장료 조성물 | |
| CN113081874A (zh) | 一种基于肤质的个性化美容方法 | |
| CN113384497B (zh) | 一种双重保湿修复和改善皮肤弹性的组合物及化妆品 | |
| DE202019005637U1 (de) | Topische Muskelentspannungszusammensetzungen und deren Verwendung | |
| CN113368003A (zh) | 一种具有熬夜肌修护功效的组合物及其制备方法和应用 | |
| CN113081942A (zh) | 一种含有苹果干细胞的多维水合霜 | |
| CN112220693A (zh) | 含挪威云杉叶提取物的晒后修护固态喷雾及其制备方法 | |
| KR20110052095A (ko) | 흰목이 버섯 추출물을 함유하는 피부 보습용 화장료 조성물 | |
| CN116999358A (zh) | 一种应用于皮肤屏障修护和舒缓的面膜及制备方法 | |
| CN115778870A (zh) | 一种抗皱抗衰老的组合物及其制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |